Development of a bioassay to monitor circulating plasma Ki-67.
作者信息
Hardiman Gary
出版信息
Leuk Res. 2010 Jul;34(7):848-9. doi: 10.1016/j.leukres.2010.01.007. Epub 2010 Feb 20.
Abstract
摘要
相似文献
1
Development of a bioassay to monitor circulating plasma Ki-67.一种用于监测循环血浆中Ki-67的生物测定法的开发。
Leuk Res. 2010 Jul;34(7):848-9. doi: 10.1016/j.leukres.2010.01.007. Epub 2010 Feb 20.
2
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.血浆中循环 Ki-67 蛋白作为急性淋巴细胞白血病的生物标志物和预后指标
Leuk Res. 2010 Feb;34(2):173-6. doi: 10.1016/j.leukres.2009.07.030. Epub 2009 Aug 12.
3
Highlights from the field of biomarkers in prostate cancer. [corrected].
Biomark Med. 2014;8(7):917-9. doi: 10.2217/bmm.14.59.
4
IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.慢性肝病患者血清中的 IgM 结合型 SerpinB3 和 SerpinB4。
PLoS One. 2012;7(7):e40658. doi: 10.1371/journal.pone.0040658. Epub 2012 Jul 13.
5
[Small intestinal mucin antigen (SIMA)].
Nihon Rinsho. 2005 Aug;63 Suppl 8:730-2.
6
Squamous cell carcinoma antigen isoforms in serum from cervical cancer patients.宫颈癌患者血清中的鳞状细胞癌抗原异构体
Tumour Biol. 2006;27(3):142-52. doi: 10.1159/000092775. Epub 2006 Apr 20.
7
Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.系统性红斑狼疮患者血浆中催乳素的分子异质性
Arthritis Rheum. 2001 Jun;44(6):1331-5. doi: 10.1002/1529-0131(200106)44:6<1331::AID-ART225>3.0.CO;2-Q.
8
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions.测定碳酸酐酶 IX 作为缺氧生物标志物：由于金属离子的影响，使用商业酶联免疫吸附测定法测量血清和血浆中浓度的差异。
Ann Clin Biochem. 2011 Mar;48(Pt 2):112-20. doi: 10.1258/acb.2010.010240. Epub 2011 Mar 2.
9
Improved ELISA proliferation assay (EPA) for the detection of in vitro cell proliferation by a new Ki-67-antigen directed monoclonal antibody (Ki-S3).
J Immunol Methods. 1998 Feb 1;211(1-2):43-50. doi: 10.1016/s0022-1759(97)00175-0.
10
Development of an affinity-column-mediated enzyme-linked immunosorbent assay for ferritin.
Clin Chim Acta. 1998 May 8;273(1):81-7. doi: 10.1016/s0009-8981(98)00018-7.
本文引用的文献
1
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.血浆中循环 Ki-67 蛋白作为急性淋巴细胞白血病的生物标志物和预后指标
Leuk Res. 2010 Feb;34(2):173-6. doi: 10.1016/j.leukres.2009.07.030. Epub 2009 Aug 12.
2
Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.Ki-67指数在非霍奇金淋巴瘤中的作用及预后意义
Am J Hematol. 2009 Jun;84(6):338-43. doi: 10.1002/ajh.21406.
3
Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.评估半胱天冬酶-3表达与伯基特淋巴瘤及伯基特样淋巴瘤临床结局之间的关系。
Cancer Sci. 2008 Aug;99(8):1564-9. doi: 10.1111/j.1349-7006.2008.00851.x.
4
Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.携带靶向Ki-67编码mRNA的短发夹RNA的溶瘤腺病毒在体外和体内对肾癌细胞生长的抑制作用
Cancer Gene Ther. 2009 Jan;16(1):20-32. doi: 10.1038/cgt.2008.61. Epub 2008 Aug 8.
5
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.乳腺癌新辅助化疗前后Ki67的预后意义
Breast Cancer Res Treat. 2009 Jul;116(1):53-68. doi: 10.1007/s10549-008-0081-7. Epub 2008 Jul 1.
6
Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.Ki-67抗原表达在非霍奇金淋巴瘤中的预后意义
Anticancer Res. 2008 Mar-Apr;28(2A):1113-8.
7
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?Ki67和细胞周期蛋白A作为早期乳腺癌的预后因素。最佳临界值是多少？
Histopathology. 2007 Oct;51(4):491-8. doi: 10.1111/j.1365-2559.2007.02798.x. Epub 2007 Aug 17.
8
Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.回复：原发性乳腺癌术前短期内分泌治疗后Ki67表达的预后价值
J Natl Cancer Inst. 2007 Jul 4;99(13):1053; author reply 1053-4. doi: 10.1093/jnci/djm019. Epub 2007 Jun 27.
9
Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer.评估雌激素受体（ER）和Ki-67增殖指数作为多柔比星/多西他赛新辅助化疗治疗局部晚期乳腺癌后生存预后因素的情况。
Cancer Chemother Pharmacol. 2008 Apr;61(4):569-77. doi: 10.1007/s00280-007-0506-8. Epub 2007 May 17.
10
Ki67 protein: the immaculate deception?Ki67蛋白：完美的骗局？
Histopathology. 2002 Jan;40(1):2-11. doi: 10.1046/j.1365-2559.2002.01343.x.
Zotero 插件